annual operating expenses:
$188.47M-$64.59M(-25.52%)Summary
- As of today (May 24, 2025), AUPH annual total operating expenses is $188.47 million, with the most recent change of -$64.59 million (-25.52%) on December 31, 2024.
- During the last 3 years, AUPH annual operating expenses has fallen by -$36.78 million (-16.33%).
- AUPH annual operating expenses is now -25.52% below its all-time high of $253.06 million, reached on December 31, 2023.
Performance
AUPH Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$30.51M-$10.12M(-24.91%)Summary
- As of today (May 24, 2025), AUPH quarterly total operating expenses is $30.51 million, with the most recent change of -$10.12 million (-24.91%) on March 31, 2025.
- Over the past year, AUPH quarterly operating expenses has dropped by -$18.61 million (-37.89%).
- AUPH quarterly operating expenses is now -56.02% below its all-time high of $69.37 million, reached on December 31, 2023.
Performance
AUPH quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AUPH Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.5% | -37.9% |
| 3 y3 years | -16.3% | -48.5% |
| 5 y5 years | +106.5% | +21.2% |
AUPH Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.5% | at low | -56.0% | at low |
| 5 y | 5-year | -25.5% | +106.5% | -56.0% | +21.2% |
| alltime | all time | -25.5% | +9811.4% | -56.0% | >+9999.0% |
AUPH Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $30.51M(-24.9%) |
| Dec 2024 | $188.47M(-25.5%) | $40.63M(-18.7%) |
| Sep 2024 | - | $49.99M(+2.6%) |
| Jun 2024 | - | $48.72M(-0.8%) |
| Mar 2024 | - | $49.12M(-29.2%) |
| Dec 2023 | $253.06M(+5.5%) | $69.37M(+8.4%) |
| Sep 2023 | - | $64.01M(+14.1%) |
| Jun 2023 | - | $56.10M(-11.8%) |
| Mar 2023 | - | $63.57M(+15.2%) |
| Dec 2022 | $239.84M(+6.5%) | $55.17M(-12.2%) |
| Sep 2022 | - | $62.83M(+0.4%) |
| Jun 2022 | - | $62.58M(+5.6%) |
| Mar 2022 | - | $59.25M(+6.5%) |
| Dec 2021 | $225.25M(+45.9%) | $55.63M(-14.1%) |
| Sep 2021 | - | $64.77M(+21.2%) |
| Jun 2021 | - | $53.45M(+4.0%) |
| Mar 2021 | - | $51.41M(-11.5%) |
| Dec 2020 | $154.41M(+69.2%) | $58.08M(+37.2%) |
| Sep 2020 | - | $42.34M(+57.5%) |
| Jun 2020 | - | $26.89M(+6.8%) |
| Mar 2020 | - | $25.17M(-29.3%) |
| Dec 2019 | $91.26M(+61.9%) | $35.62M(+46.9%) |
| Sep 2019 | - | $24.24M(+47.1%) |
| Jun 2019 | - | $16.48M(+10.5%) |
| Mar 2019 | - | $14.91M(+3.3%) |
| Dec 2018 | $56.37M(+18.7%) | $14.44M(-0.3%) |
| Sep 2018 | - | $14.48M(+0.8%) |
| Jun 2018 | - | $14.37M(+9.9%) |
| Mar 2018 | - | $13.08M(+7.5%) |
| Dec 2017 | $47.48M(+106.6%) | $12.17M(-11.9%) |
| Sep 2017 | - | $13.82M(+33.2%) |
| Jun 2017 | - | $10.38M(-6.6%) |
| Mar 2017 | - | $11.12M(+38.0%) |
| Dec 2016 | $22.98M(-3.4%) | $8.05M(+48.6%) |
| Sep 2016 | - | $5.42M(+17.7%) |
| Jun 2016 | - | $4.61M(-6.1%) |
| Mar 2016 | - | $4.90M(-12.1%) |
| Dec 2015 | $23.80M(+35.8%) | $5.58M(-14.0%) |
| Sep 2015 | - | $6.48M(+6.2%) |
| Jun 2015 | - | $6.11M(+8.4%) |
| Mar 2015 | - | $5.63M(+14.9%) |
| Dec 2014 | $17.52M(+242.1%) | $4.90M(+16.4%) |
| Sep 2014 | - | $4.21M(-9.0%) |
| Jun 2014 | - | $4.63M(+22.4%) |
| Mar 2014 | - | $3.78M(+79.8%) |
| Dec 2013 | $5.12M(-55.8%) | $2.10M(+92.1%) |
| Sep 2013 | - | $1.09M(+8.1%) |
| Jun 2013 | - | $1.01M(+11.2%) |
| Mar 2013 | - | $911.00K(-84.1%) |
| Dec 2012 | $11.58M(+61.2%) | $5.72M(+223.5%) |
| Sep 2012 | - | $1.77M(-11.0%) |
| Jun 2012 | - | $1.99M(-0.9%) |
| Mar 2012 | - | $2.01M(+1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $7.18M(-14.7%) | $1.98M(+21.3%) |
| Sep 2011 | - | $1.63M(-20.2%) |
| Jun 2011 | - | $2.04M(+15.1%) |
| Mar 2011 | - | $1.78M(-25.8%) |
| Dec 2010 | $8.42M(-31.9%) | $2.39M(+44.6%) |
| Sep 2010 | - | $1.66M(-17.6%) |
| Jun 2010 | - | $2.01M(-14.3%) |
| Mar 2010 | - | $2.34M(-29.0%) |
| Dec 2009 | $12.37M(-28.9%) | $3.30M(+24.0%) |
| Sep 2009 | - | $2.66M(+1.0%) |
| Jun 2009 | - | $2.64M(-11.8%) |
| Mar 2009 | - | $2.99M(+76.0%) |
| Dec 2008 | $17.38M(-53.2%) | $1.70M(-63.5%) |
| Sep 2008 | - | $4.66M(-21.0%) |
| Jun 2008 | - | $5.90M(+7.4%) |
| Mar 2008 | - | $5.50M(-40.5%) |
| Dec 2007 | $37.17M(+37.3%) | $9.23M(+9.6%) |
| Sep 2007 | - | $8.42M(-16.0%) |
| Jun 2007 | - | $10.03M(+30.6%) |
| Mar 2007 | - | $7.68M(+16.6%) |
| Dec 2006 | $27.08M(-13.9%) | $6.59M(-6.3%) |
| Sep 2006 | - | $7.03M(+0.5%) |
| Jun 2006 | - | $7.00M(+11.9%) |
| Mar 2006 | - | $6.25M(-30.3%) |
| Dec 2005 | $31.47M(+28.8%) | $8.97M(+23.7%) |
| Sep 2005 | - | $7.25M(+3.1%) |
| Jun 2005 | - | $7.04M(-7.9%) |
| Mar 2005 | - | $7.64M(-14.8%) |
| Dec 2004 | $24.43M(+29.4%) | $8.97M(+29.2%) |
| Sep 2004 | - | $6.94M(+63.4%) |
| Jun 2004 | - | $4.25M(+9.6%) |
| Mar 2004 | - | $3.88M(-34.6%) |
| Dec 2003 | $18.88M(+40.3%) | $5.93M(+33.3%) |
| Sep 2003 | - | $4.45M(+101.9%) |
| Jun 2003 | - | $2.20M(-36.2%) |
| Mar 2003 | - | $3.45M(-12.9%) |
| Dec 2002 | $13.46M(+14.1%) | $3.96M(+75.2%) |
| Sep 2002 | - | $2.26M(-22.7%) |
| Jun 2002 | - | $2.93M(-33.9%) |
| Mar 2002 | - | $4.43M(+78.8%) |
| Dec 2001 | $11.80M(+69.5%) | - |
| Aug 2001 | - | $2.48M(-27.1%) |
| May 2001 | - | $3.40M(+39.6%) |
| Feb 2001 | - | $2.43M(-9.7%) |
| Nov 2000 | $6.96M(+266.1%) | $2.70M(+62.1%) |
| Aug 2000 | - | $1.66M(-4.1%) |
| May 2000 | - | $1.74M(+93.7%) |
| Feb 2000 | - | $895.90K(-7.1%) |
| Nov 1999 | $1.90M(-35.1%) | $964.70K(+1342.0%) |
| Aug 1999 | - | $66.90K(-87.7%) |
| May 1999 | - | $542.60K(+63.7%) |
| Feb 1999 | - | $331.50K |
| Nov 1998 | $2.93M | - |
FAQ
- What is Aurinia Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual operating expenses year-on-year change?
- What is Aurinia Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly operating expenses year-on-year change?
What is Aurinia Pharmaceuticals annual total operating expenses?
The current annual operating expenses of AUPH is $188.47M
What is the all time high annual operating expenses for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual total operating expenses is $253.06M
What is Aurinia Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, AUPH annual total operating expenses has changed by -$64.59M (-25.52%)
What is Aurinia Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of AUPH is $30.51M
What is the all time high quarterly operating expenses for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly total operating expenses is $69.37M
What is Aurinia Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, AUPH quarterly total operating expenses has changed by -$18.61M (-37.89%)